{"transactions":[{"id":1671167,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Market Stock Unit","published_at":"2024-01-25T20:24:30.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":3639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each market stock unit, which is performance-based, represents the contingent right to receive one share of common stock. The amount reported represents the target number of shares which may be issued upon vesting. The market stock units will vest upon certification concerning the Company's stock price performance measured against biotechnology stock index companies for the entire performance period ending December 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each market stock unit, which is performance-based, represents the contingent right to receive one share of common stock. The amount reported represents the target number of shares which may be issued upon vesting. The market stock units will vest upon certification concerning the Company's stock price performance measured against biotechnology stock index companies for the entire performance period ending December 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each market stock unit, which is performance-based, represents the contingent right to receive one share of common stock. The amount reported represents the target number of shares which may be issued upon vesting. The market stock units will vest upon certification concerning the Company's stock price performance measured against biotechnology stock index companies for the entire performance period ending December 31, 2026."}],"balance_after":3639,"derivative":{"underlying":"Common Stock","underlying_shares":3639},"source":{"system":"sec-edgar","filing":"0000950170-24-007348","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024007348/ownership.xml","form_type":"4"}},{"id":1671166,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T20:24:30.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":5483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (January 23, 2025) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":5483,"derivative":{"exercise_price":229,"expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":5483},"source":{"system":"sec-edgar","filing":"0000950170-24-007348","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024007348/ownership.xml","form_type":"4"}},{"id":1671165,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-01-25T20:24:30.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":3639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of January 23, 2025, January 23, 2026, January 23, 2027 and January 23, 2028, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":17691,"source":{"system":"sec-edgar","filing":"0000950170-24-007348","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024007348/ownership.xml","form_type":"4"}},{"id":1676728,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-01-18T18:52:42.000Z","date":"2024-01-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":949,"price":243.92,"value":231480.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents withholding of shares as payment of the Reporting Person's tax liabilities incident to the vesting of restricted stock units granted to the Reporting Person on January 16, 2023."}],"balance_after":14052,"source":{"system":"sec-edgar","filing":"0000950170-24-005304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024005304/ownership.xml","form_type":"4"}},{"id":1720318,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-06T21:30:08.000Z","date":"2023-12-05","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares issued pursuant to the exercise of this option represent 2,000 shares underlying an overall option award of 45,000 shares. All exercised options had vested. As to the overall option for 45,000 shares, 25% of the shares underlying the option vested on February 22, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":43000,"derivative":{"exercise_price":87.09,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0000950170-23-068575","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023068575/ownership.xml","form_type":"4"}},{"id":1720317,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-06T21:30:08.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares issued pursuant to the exercise of this option represent 2,000 shares underlying an overall option award of 45,000 shares. All exercised options had vested. As to the overall option for 45,000 shares, 25% of the shares underlying the option vested on February 22, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":44000,"derivative":{"exercise_price":87.09,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-23-068575","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023068575/ownership.xml","form_type":"4"}},{"id":1720316,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-06T21:30:08.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":false,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares issued pursuant to the exercise of this option represent 800 shares underlying an overall option award of 25,000 shares. All exercised options had vested. As to the overall option for 25,000 shares, 25% of the shares underlying the option vested on August 10, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":20200,"derivative":{"exercise_price":73.75,"expiration_date":"2032-08-10","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-23-068575","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023068575/ownership.xml","form_type":"4"}},{"id":1720315,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-06T21:30:08.000Z","date":"2023-12-05","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":227.33,"value":227330.0,"ownership":{"direct":true},"balance_after":15001,"source":{"system":"sec-edgar","filing":"0000950170-23-068575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023068575/ownership.xml","form_type":"4"}},{"id":1720314,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-06T21:30:08.000Z","date":"2023-12-05","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":87.09,"value":87090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All shares issued pursuant to the exercise of this option represent 2,000 shares underlying an overall option award of 45,000 shares. All exercised options had vested. As to the overall option for 45,000 shares, 25% of the shares underlying the option vested on February 22, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":16001,"source":{"system":"sec-edgar","filing":"0000950170-23-068575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023068575/ownership.xml","form_type":"4"}},{"id":1720313,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-06T21:30:08.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":221.38,"value":221380.0,"ownership":{"direct":true},"balance_after":15001,"source":{"system":"sec-edgar","filing":"0000950170-23-068575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023068575/ownership.xml","form_type":"4"}},{"id":1720312,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-06T21:30:08.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":800,"price":215.73,"value":172584.0,"ownership":{"direct":true},"balance_after":16001,"source":{"system":"sec-edgar","filing":"0000950170-23-068575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023068575/ownership.xml","form_type":"4"}},{"id":1720311,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-06T21:30:08.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":87.09,"value":87090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All shares issued pursuant to the exercise of this option represent 2,000 shares underlying an overall option award of 45,000 shares. All exercised options had vested. As to the overall option for 45,000 shares, 25% of the shares underlying the option vested on February 22, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":16801,"source":{"system":"sec-edgar","filing":"0000950170-23-068575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023068575/ownership.xml","form_type":"4"}},{"id":1720310,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-06T21:30:08.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":true,"shares":800,"price":73.75,"value":59000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All shares issued pursuant to the exercise of this option represent 800 shares underlying an overall option award of 25,000 shares. All exercised options had vested. As to the overall option for 25,000 shares, 25% of the shares underlying the option vested on August 10, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":15801,"source":{"system":"sec-edgar","filing":"0000950170-23-068575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023068575/ownership.xml","form_type":"4"}},{"id":1725748,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-01T21:30:07.000Z","date":"2023-11-30","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares issued pursuant to the exercise of the options reported herein represent 7,000 shares underlying an overall option award of 25,000 shares. All exercised options had vested. As to the overall option for 25,000 shares, 25% of the shares underlying the option vested on August 10, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":18000,"derivative":{"exercise_price":73.75,"expiration_date":"2032-08-10","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000950170-23-067360","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023067360/ownership.xml","form_type":"4"}},{"id":1725747,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-01T21:30:07.000Z","date":"2023-11-29","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares issued pursuant to the exercise of the options reported herein represent 7,000 shares underlying an overall option award of 25,000 shares. All exercised options had vested. As to the overall option for 25,000 shares, 25% of the shares underlying the option vested on August 10, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":21000,"derivative":{"exercise_price":73.75,"expiration_date":"2032-08-10","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000950170-23-067360","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023067360/ownership.xml","form_type":"4"}},{"id":1725746,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-01T21:30:07.000Z","date":"2023-11-30","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":206.73,"value":206730.0,"ownership":{"direct":true},"balance_after":15001,"source":{"system":"sec-edgar","filing":"0000950170-23-067360","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023067360/ownership.xml","form_type":"4"}},{"id":1725745,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-01T21:30:07.000Z","date":"2023-11-30","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":203,"value":203000.0,"ownership":{"direct":true},"balance_after":16001,"source":{"system":"sec-edgar","filing":"0000950170-23-067360","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023067360/ownership.xml","form_type":"4"}},{"id":1725744,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-01T21:30:07.000Z","date":"2023-11-30","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":204,"value":204000.0,"ownership":{"direct":true},"balance_after":17001,"source":{"system":"sec-edgar","filing":"0000950170-23-067360","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023067360/ownership.xml","form_type":"4"}},{"id":1725743,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-01T21:30:07.000Z","date":"2023-11-30","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":73.75,"value":221250.0,"ownership":{"direct":true},"balance_after":18001,"source":{"system":"sec-edgar","filing":"0000950170-23-067360","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023067360/ownership.xml","form_type":"4"}},{"id":1725742,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-01T21:30:07.000Z","date":"2023-11-29","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":199.45,"value":598350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.25 to $199.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote"}],"balance_after":15001,"source":{"system":"sec-edgar","filing":"0000950170-23-067360","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023067360/ownership.xml","form_type":"4"}},{"id":1725741,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-01T21:30:07.000Z","date":"2023-11-29","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":198.4,"value":198400.0,"ownership":{"direct":true},"balance_after":18001,"source":{"system":"sec-edgar","filing":"0000950170-23-067360","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023067360/ownership.xml","form_type":"4"}},{"id":1725740,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-12-01T21:30:07.000Z","date":"2023-11-29","kind":"exercise","planned":false,"acquired":true,"shares":4000,"price":73.75,"value":295000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All shares issued pursuant to the exercise of the options reported herein represent 7,000 shares underlying an overall option award of 25,000 shares. All exercised options had vested. As to the overall option for 25,000 shares, 25% of the shares underlying the option vested on August 10, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":19001,"source":{"system":"sec-edgar","filing":"0000950170-23-067360","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023067360/ownership.xml","form_type":"4"}},{"id":2052790,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-19T01:00:22.000Z","date":"2023-01-16","kind":"grant","acquired":true,"shares":15001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of January 13, 2024, January 13, 2025, January 13, 2026 and January 13, 2027, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":15001,"source":{"system":"sec-edgar","filing":"0000899243-23-002097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323002097/doc4.xml","form_type":"4"}},{"id":2060802,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares issued pursuant to the exercise of the options reported herein represent 13,000 shares underlying an overall option award of 32,000 shares. All exercised options had vested. As to the overall option for 32,000 shares, 25% of the shares underlying the option vested on March 5, 2021 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":12000,"derivative":{"exercise_price":91.79,"expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2060801,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":100,"price":287.86,"value":28786.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $287.86 to $287.86, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2060800,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":400,"price":286.62,"value":114648.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $286.61 to $286.63, inclusive."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2060799,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":2038,"price":285.74,"value":582338.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $285.50 to $286.29, inclusive."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2060798,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":829,"price":285.15,"value":236389.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $284.50 to $285.49, inclusive."}],"balance_after":2538,"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2060797,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":1549,"price":283.85,"value":439683.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.42 to $284.21, inclusive."}],"balance_after":3367,"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2060796,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":2628,"price":282.97,"value":743645.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.41 to $283.33, inclusive."}],"balance_after":4916,"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2060795,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":2656,"price":281.97,"value":748912.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.32 to $282.30, inclusive."}],"balance_after":7544,"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2060794,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":1800,"price":280.66,"value":505188.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.22 to $281.16, inclusive."}],"balance_after":10200,"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2060793,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":400,"price":279.1,"value":111640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.06 to $279.38, inclusive."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2060792,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":600,"price":277.91,"value":166746.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.90 to $277.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":12400,"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2060791,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T14:08:05.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":13000,"price":91.79,"value":1193270.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0000899243-23-001137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924323001137/doc4.xml","form_type":"4"}},{"id":2075683,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares issued pursuant to the exercise of the options reported herein represent 7,000 shares underlying an overall option award of 32,000 shares. All exercised options had vested. As to the overall option for 32,000 shares, 25% of the shares underlying the option vested on March 5, 2021 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":25000,"derivative":{"exercise_price":91.79,"expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075682,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":200,"price":283.61,"value":56722.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.22 to 284.00, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075681,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":200,"price":281.79,"value":56358.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.45 to $282.14, inclusive."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075680,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":200,"price":280.41,"value":56082.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.17 to $280.66, inclusive."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075679,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":1100,"price":279.46,"value":307406.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.00 to $279.95, inclusive."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075678,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":361,"price":277.77,"value":100274.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.51 to $278.13, inclusive."}],"balance_after":1700,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075677,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":100,"price":276.4,"value":27640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2061,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075676,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":100,"price":275.24,"value":27524.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2161,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075675,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":400,"price":274.7,"value":109880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.24 to $275.04, inclusive."}],"balance_after":2261,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075674,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":539,"price":273.48,"value":147405.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.19 to $273.95, inclusive."}],"balance_after":2661,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075673,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":1500,"price":272.74,"value":409110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.18 to $273.14, inclusive."}],"balance_after":3200,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075672,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":800,"price":271.27,"value":217016.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.87 to $271.85, inclusive."}],"balance_after":4700,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075671,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":700,"price":270.25,"value":189175.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.72 to $270.69, inclusive."}],"balance_after":5500,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075670,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":300,"price":268.99,"value":80697.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.64 to $269.54, inclusive."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075669,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":500,"price":267.88,"value":133940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.32 to $268.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2075668,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-29T01:00:22.000Z","date":"2022-12-23","kind":"exercise","acquired":true,"shares":7000,"price":91.79,"value":642530.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0000899243-22-039464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322039464/doc4.xml","form_type":"4"}},{"id":2187186,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-12T20:30:39.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (08/10/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":25000,"derivative":{"exercise_price":73.75,"expiration_date":"2032-08-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-22-028491","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322028491/doc4.xml","form_type":"4"}},{"id":2375355,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Councel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-25T01:18:22.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":45000,"derivative":{"exercise_price":87.09,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-22-007776","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924322007776/doc4.xml","form_type":"4"}},{"id":2839923,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Councel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-23T18:29:31.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":32000,"derivative":{"exercise_price":119.49,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0000899243-21-007759","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924321007759/doc4.xml","form_type":"4"}},{"id":3063694,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-10T23:07:21.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (August 6, 2021) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":20000,"derivative":{"exercise_price":103.1,"expiration_date":"2030-08-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-20-021949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320021949/doc4.xml","form_type":"4"}},{"id":3224831,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":94905,"kind":"person","name":"Lynch Brian Joseph","position":1,"cik":"0001776196","reported_name":"Lynch Brian Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Councel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-05T22:05:08.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (March 5, 2021) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":32000,"derivative":{"exercise_price":91.79,"expiration_date":"2030-03-05","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0000899243-20-007223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320007223/doc4.xml","form_type":"4"}}]}